Filing Details
- Accession Number:
- 0001104659-20-139953
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-28 21:03:30
- Reporting Period:
- 2020-12-22
- Accepted Time:
- 2020-12-28 21:03:30
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1737953 | Replimune Group Inc. | REPL | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1376492 | Robert Coffin | C/O Replimune Group, Inc. 500 Unicorn Park Woburn MA 01801 | President & Chief R&D Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-12-22 | 220,000 | $40.04 | 1,804,118 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on November 16, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended.
- Following the sales reported on this Form 4, the reporting person continues to beneficially own 1,804,118 shares of the Issuer's common stock. The reporting person also holds options to acquire 977,599 shares of the Issuer's common stock, 468,928 of which are exercisable as of the date hereof.